This study evaluates patient experience with PET imaging in order to come up with ways to improve the diagnosis for patients, and the ways that tests are chosen and explained by doctors.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06523777.
Locations matching your search criteria
United States
Connecticut
New Haven
Yale UniversityStatus: Active
Contact: Michael S. Leapman
Phone: 203-785-3128
PRIMARY OBJECTIVE:
I. To examine changes in serial quantitative psychological (anxiety, uncertainty) and HRQoL survey data from patients undergoing PET imaging for prostate cancer.
OUTLINE: This is an observational study.
PHASE 1: Patients complete surveys on study.
PHASE 2: A subset of patients from Phase 1 participate in an interview on study.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationYale University
Principal InvestigatorMichael S. Leapman
